MAPT and Alzheimer disease: In 2021, Wang et al. discovered C004019 (Figure 6B), a novel small-molecule PROTAC that selectively promotes tau clearance, significantly improving synaptic and cognitive functions in various hTau cell models and in AD-like hTau and 3xTg transgenic mice.